Your browser doesn't support javascript.
loading
Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention: An analysis from the e-Ultimaster registry.
Kobo, Ofer; Levi, Yaniv; Abu-Fanne, Rami; Von Birgelen, Clemens; Guédès, Antoine; Aminian, Adel; Laanmets, Peep; Dewilde, Willem; Witkowski, Adam; Monsegu, Jacques; Romo Iniguez, Andres; Halabi, Majdi; Mamas, Mamas A; Roguin, Ariel.
Afiliación
  • Kobo O; Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
  • Levi Y; Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
  • Abu-Fanne R; Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
  • Von Birgelen C; Thoraxcentrum Twente, Medisch Spectrum Twente, and Department Health Technology and Services Research, University of Twente, Enschede, The Netherlands.
  • Guédès A; CHU UCL Namur, Site de Mont Godinne, Université catholique de Louvain, Belgium.
  • Aminian A; Centre Hospitalier Universitaire de Charleroi, Charleroi, Belgium.
  • Laanmets P; North Estonia Medical Center Foundation, Tallinn, Estonia.
  • Dewilde W; Imelda Hospital, Bonheiden, Belgium.
  • Witkowski A; Institute of Cardiology, Warsaw, Poland.
  • Monsegu J; Institut Cardio-Vasculaire, Groupe Hospitalier Mutualiste, Grenoble, France.
  • Romo Iniguez A; Hospital Álvaro Cunqueiro, Vigo, Spain.
  • Halabi M; Ziv Medical Center, Zfat, Israel.
  • Mamas MA; Keele Cardiovascular Research Group, Centre for Prognosis Research, Institutes of Applied Clinical Science and Primary Care and Health Sciences, Keele University, Keele, Newcastle, United Kingdom.
  • Roguin A; Hillel Yaffe Medical Center, Technion-Faculty of Medicine, Hadera, Israel.
Int J Cardiol Heart Vasc ; 51: 101370, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38628296
ABSTRACT

Aims:

A substantial proportion of the patients undergoing percutaneous coronary intervention (PCI) have none of the of standard modifiable cardiovascular risk factors (SMuRFs) hypertension, diabetes, hypercholesterolaemia and smoking. The aim of this analysis was to compare clinical outcomes after PCI according to the number of SMuRFs.

Methods:

Patients with an indication for a PCI were stratified based upon the number of SMuRFs 0, 1, 2 or 3-4. The primary outcome was target lesion failure (TLF), a composite of cardiac death, target vessel-related myocardial infarction or clinically driven target lesion revascularization at 1-year. Inverse weighted propensity score (IWPS) adjustment was performed to adjust for differences in baseline characteristics.

Results:

The prevalence of SMuRFs was 0 SMuRF 16.4 %; 1 SMuRF 27.8 %; 2 SMuRFs 34.7 % and 3-4 SMuRFs 21.1 %. Patients without SMuRFs were younger, more likely to be male and had less complex coronary artery disease. The incidence of TLF increased with the number of SMuRFs 2.65 %, 2.75 %, 3.23 %, and 4.24 %, Ptrend < 0.001. The relative risk (RR) for a TLF was 60 % higher (95 % confidence interval 1.32-1.93, p < 0.01) for patients with 3-4 SMuRFs compared to patients without SMuRFs. The trend remained (Ptrend < 0.01) after IWPS with TLF rates of 2.88 %, 2.64 %, 2.88 % and 3.65 %. The RR for a TLF was 27 % higher (95 % CI 1.05-1.53, p < 0.01).

Conclusion:

The incidence of clinical events at 1-year increased with the number of SMuRFs. While patients without SMuRFs have a relatively favourable risk profile, more research is needed to optimize therapeutic management in the majority of patients.
Palabras clave